Capricor Therapeutics, Inc. News: Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
04/01/24 | Annual report to security holders | 168 | |||
03/11/24 | Annual report pursuant to Section 13 and 15(d) | 134 | |||
04/21/23 | Annual report to security holders | 172 | |||
03/17/23 | Annual report pursuant to Section 13 and 15(d) | 179 | |||
03/11/22 | Annual report pursuant to Section 13 and 15(d) | 220 | |||
03/15/21 | Annual report pursuant to Section 13 and 15(d) | 82 | |||
03/27/20 | Annual report pursuant to Section 13 and 15(d) | 120 | |||
04/01/19 | Annual report pursuant to Section 13 and 15(d) | 16 | |||
03/29/19 | Annual report pursuant to Section 13 and 15(d) | 134 | |||
03/22/18 | Annual report pursuant to Section 13 and 15(d) | 125 |